Clinical Factors and Adverse Kidney Outcomes in Children With Antineutrophil Cytoplasmic Antibody–Associated Glomerulonephritis

Matko Marlais; Tanja Wlodkowski; Nikoleta Printza; Dorothea Kronsteiner; Regina Krisam; Lukas Sauer; Marina Aksenova; Isa Ashoor; Atif Awan; Justine Bacchetta; Ramnath Balasubramanian; Biswanath Basu; Zivile Bekassy; Olivia Boyer; Eugene Yu hin Chan; Dagmar Csaicsich; Stéphane Decramer; Eiske Dorresteijn; Magdalena Drozynska-Duklas; Loai Akram Eid; Laura Espinosa; Verónica Ferraris; Hana Flögelová; Jessica Forero-Delgadillo; Alessandra Gianviti; Valentina Gracchi; Mercedes López González; Matthias Hansen; Motoshi Hattori; Xu Hong; Nakysa Hooman; Dmytro Ivanov; Hee Gyung Kang; Vasiliki Karava; Ina Kazyra; Adrian Lungu; Stephen Marks; Andrew Maxted; Anna Moczulska; Rebekka Müller; Tatiana Nastausheva; Mattia Parolin; Carmine Pecoraro; Iliana Principi; Cheryl Sanchez-Kazi; Seha Saygili; Raphael Schild; Mohan Shenoy; Rajiv Sinha; Ana Paula Spizzirri; Maria Stack; Maria Szczepanska; Alexey Tsygin; Julia Tzeng; Vaidotas Urbonas; Carlos Zapata; Jakub Zieg; Franz Schaefer; Marina Vivarelli; Kjell Tullus

doi:10.1053/j.ajkd.2022.05.013

Clinical Factors and Adverse Kidney Outcomes in Children With Antineutrophil Cytoplasmic Antibody–Associated Glomerulonephritis

Matko Marlais^*, Tanja Wlodkowski, Nikoleta Printza, Dorothea Kronsteiner, Regina Krisam, Lukas Sauer, Marina Aksenova, Isa Ashoor, Atif Awan, Justine Bacchetta, Ramnath Balasubramanian, Biswanath Basu, Zivile Bekassy, Olivia Boyer, Eugene Yu hin Chan, Dagmar Csaicsich, Stéphane Decramer, Eiske Dorresteijn, Magdalena Drozynska-Duklas, Loai Akram EidLaura Espinosa, Verónica Ferraris, Hana Flögelová, Jessica Forero-Delgadillo, Alessandra Gianviti, Valentina Gracchi, Mercedes López González, Matthias Hansen, Motoshi Hattori, Xu Hong, Nakysa Hooman, Dmytro Ivanov, Hee Gyung Kang, Vasiliki Karava, Ina Kazyra, Adrian Lungu, Stephen Marks, Andrew Maxted, Anna Moczulska, Rebekka Müller, Tatiana Nastausheva, Mattia Parolin, Carmine Pecoraro, Iliana Principi, Cheryl Sanchez-Kazi, Seha Saygili, Raphael Schild, Mohan Shenoy, Rajiv Sinha, Ana Paula Spizzirri, Maria Stack, Maria Szczepanska, Alexey Tsygin, Julia Tzeng, Vaidotas Urbonas, Carlos Zapata, Jakub Zieg, Franz Schaefer, Marina Vivarelli, Kjell Tullus

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

4 Citations (Scopus)

15 Downloads (Pure)

Original language	English
Pages (from-to)	119-122
Number of pages	4
Journal	American Journal of Kidney Diseases
Volume	81
Issue number	1
DOIs	https://doi.org/10.1053/j.ajkd.2022.05.013
Publication status	Published - Jan-2023

Access to Document

10.1053/j.ajkd.2022.05.013

Clinical Factors and Adverse Kidney Outcomes in Children With Antineutrophil Cytoplasmic AntibodyFinal publisher's version, 243 KBLicence: Taverne

Handle.net

Persistent link

Cite this

Marlais, M., Wlodkowski, T., Printza, N., Kronsteiner, D., Krisam, R., Sauer, L., Aksenova, M., Ashoor, I., Awan, A., Bacchetta, J., Balasubramanian, R., Basu, B., Bekassy, Z., Boyer, O., Chan, E. Y. H., Csaicsich, D., Decramer, S., Dorresteijn, E., Drozynska-Duklas, M., ... Tullus, K. (2023). Clinical Factors and Adverse Kidney Outcomes in Children With Antineutrophil Cytoplasmic Antibody–Associated Glomerulonephritis. American Journal of Kidney Diseases, 81(1), 119-122. https://doi.org/10.1053/j.ajkd.2022.05.013

@article{43a69db5a3234e1a98c46027d34b50fa,

title = "Clinical Factors and Adverse Kidney Outcomes in Children With Antineutrophil Cytoplasmic Antibody–Associated Glomerulonephritis",

author = "Matko Marlais and Tanja Wlodkowski and Nikoleta Printza and Dorothea Kronsteiner and Regina Krisam and Lukas Sauer and Marina Aksenova and Isa Ashoor and Atif Awan and Justine Bacchetta and Ramnath Balasubramanian and Biswanath Basu and Zivile Bekassy and Olivia Boyer and Chan, {Eugene Yu hin} and Dagmar Csaicsich and St{\'e}phane Decramer and Eiske Dorresteijn and Magdalena Drozynska-Duklas and Eid, {Loai Akram} and Laura Espinosa and Ver{\'o}nica Ferraris and Hana Fl{\"o}gelov{\'a} and Jessica Forero-Delgadillo and Alessandra Gianviti and Valentina Gracchi and Gonz{\'a}lez, {Mercedes L{\'o}pez} and Matthias Hansen and Motoshi Hattori and Xu Hong and Nakysa Hooman and Dmytro Ivanov and Kang, {Hee Gyung} and Vasiliki Karava and Ina Kazyra and Adrian Lungu and Stephen Marks and Andrew Maxted and Anna Moczulska and Rebekka M{\"u}ller and Tatiana Nastausheva and Mattia Parolin and Carmine Pecoraro and Iliana Principi and Cheryl Sanchez-Kazi and Seha Saygili and Raphael Schild and Mohan Shenoy and Rajiv Sinha and Spizzirri, {Ana Paula} and Maria Stack and Maria Szczepanska and Alexey Tsygin and Julia Tzeng and Vaidotas Urbonas and Carlos Zapata and Jakub Zieg and Franz Schaefer and Marina Vivarelli and Kjell Tullus",

note = "Funding Information: This study has been supported by the European Rare Kidney Disease Network (ERKNet). ERKNet is co-funded by the European Union within the framework of the Third Health Programme “ERN-2016 - Framework Partnership Agreement 2017-2021.” The funders had no role in study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication. Funding Information: Designed the study, collected and collated data, conducted and reviewed analyses: MM, TW, NP, FS, MV, KT; devised the statistical analysis plan, conducted statistical analyses: DK, RK, LS; reviewed patients for inclusion, collected data: MA, IA, AA, JB, RB, BB, ZB, OB, EY-hC, DC, SD, ED, MD-D, LAE, LE, VF, HF, JF-D, AG, VG, MLG, MHansen, MHattori, XH, NH, DI, HGK, VK, IK, AL, SM, AMaxted, AMoczulska, RM, TN, MP, CP, IP, CS-K, SS, RSchild, MS, RSinha, APS, MStack, MSzczepanska, AT, JT, VU, CZ, JZ. Each author contributed important intellectual content during manuscript drafting or revision and agrees to be personally accountable for the individual's own contributions and to ensure that questions pertaining to the accuracy or integrity of any portion of the work, even one in which the author was not directly involved, are appropriately investigated and resolved, including with documentation in the literature if appropriate. This study has been supported by the European Rare Kidney Disease Network (ERKNet). ERKNet is co-funded by the European Union within the framework of the Third Health Programme “ERN-2016 - Framework Partnership Agreement 2017-2021.” The funders had no role in study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication. The authors declare that they have no relevant financial interests. We are grateful to the European Society of Paediatric Nephrology (ESPN) and the International Paediatric Nephrology Association (IPNA) for their support in administering this study. We are grateful to all colleagues and pediatric nephrology centers contributing cases to this study. Aspects of this work were presented in abstract form at the 53rd ESPN Annual Meeting held in Amsterdam, The Netherlands, in September 2021. Received February 11, 2022. Evaluated by 2 external peer reviewers, with direct editorial input from a Statistics/Methods Editor, an Associate Editor, and the Editor-in-Chief. Accepted in revised form May 18, 2022.",

year = "2023",

month = jan,

doi = "10.1053/j.ajkd.2022.05.013",

language = "English",

volume = "81",

pages = "119--122",

journal = "American Journal of Kidney Diseases",

issn = "0272-6386",

publisher = "W B SAUNDERS CO-ELSEVIER INC",

number = "1",

}

Marlais, M, Wlodkowski, T, Printza, N, Kronsteiner, D, Krisam, R, Sauer, L, Aksenova, M, Ashoor, I, Awan, A, Bacchetta, J, Balasubramanian, R, Basu, B, Bekassy, Z, Boyer, O, Chan, EYH, Csaicsich, D, Decramer, S, Dorresteijn, E, Drozynska-Duklas, M, Eid, LA, Espinosa, L, Ferraris, V, Flögelová, H, Forero-Delgadillo, J, Gianviti, A, Gracchi, V, González, ML, Hansen, M, Hattori, M, Hong, X, Hooman, N, Ivanov, D, Kang, HG, Karava, V, Kazyra, I, Lungu, A, Marks, S, Maxted, A, Moczulska, A, Müller, R, Nastausheva, T, Parolin, M, Pecoraro, C, Principi, I, Sanchez-Kazi, C, Saygili, S, Schild, R, Shenoy, M, Sinha, R, Spizzirri, AP, Stack, M, Szczepanska, M, Tsygin, A, Tzeng, J, Urbonas, V, Zapata, C, Zieg, J, Schaefer, F, Vivarelli, M & Tullus, K 2023, 'Clinical Factors and Adverse Kidney Outcomes in Children With Antineutrophil Cytoplasmic Antibody–Associated Glomerulonephritis', American Journal of Kidney Diseases, vol. 81, no. 1, pp. 119-122. https://doi.org/10.1053/j.ajkd.2022.05.013

TY - JOUR

T1 - Clinical Factors and Adverse Kidney Outcomes in Children With Antineutrophil Cytoplasmic Antibody–Associated Glomerulonephritis

AU - Marlais, Matko

AU - Wlodkowski, Tanja

AU - Printza, Nikoleta

AU - Kronsteiner, Dorothea

AU - Krisam, Regina

AU - Sauer, Lukas

AU - Aksenova, Marina

AU - Ashoor, Isa

AU - Awan, Atif

AU - Bacchetta, Justine

AU - Balasubramanian, Ramnath

AU - Basu, Biswanath

AU - Bekassy, Zivile

AU - Boyer, Olivia

AU - Chan, Eugene Yu hin

AU - Csaicsich, Dagmar

AU - Decramer, Stéphane

AU - Dorresteijn, Eiske

AU - Drozynska-Duklas, Magdalena

AU - Eid, Loai Akram

AU - Espinosa, Laura

AU - Ferraris, Verónica

AU - Flögelová, Hana

AU - Forero-Delgadillo, Jessica

AU - Gianviti, Alessandra

AU - Gracchi, Valentina

AU - González, Mercedes López

AU - Hansen, Matthias

AU - Hattori, Motoshi

AU - Hong, Xu

AU - Hooman, Nakysa

AU - Ivanov, Dmytro

AU - Kang, Hee Gyung

AU - Karava, Vasiliki

AU - Kazyra, Ina

AU - Lungu, Adrian

AU - Marks, Stephen

AU - Maxted, Andrew

AU - Moczulska, Anna

AU - Müller, Rebekka

AU - Nastausheva, Tatiana

AU - Parolin, Mattia

AU - Pecoraro, Carmine

AU - Principi, Iliana

AU - Sanchez-Kazi, Cheryl

AU - Saygili, Seha

AU - Schild, Raphael

AU - Shenoy, Mohan

AU - Sinha, Rajiv

AU - Spizzirri, Ana Paula

AU - Stack, Maria

AU - Szczepanska, Maria

AU - Tsygin, Alexey

AU - Tzeng, Julia

AU - Urbonas, Vaidotas

AU - Zapata, Carlos

AU - Zieg, Jakub

AU - Schaefer, Franz

AU - Vivarelli, Marina

AU - Tullus, Kjell

N1 - Funding Information: This study has been supported by the European Rare Kidney Disease Network (ERKNet). ERKNet is co-funded by the European Union within the framework of the Third Health Programme “ERN-2016 - Framework Partnership Agreement 2017-2021.” The funders had no role in study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication. Funding Information: Designed the study, collected and collated data, conducted and reviewed analyses: MM, TW, NP, FS, MV, KT; devised the statistical analysis plan, conducted statistical analyses: DK, RK, LS; reviewed patients for inclusion, collected data: MA, IA, AA, JB, RB, BB, ZB, OB, EY-hC, DC, SD, ED, MD-D, LAE, LE, VF, HF, JF-D, AG, VG, MLG, MHansen, MHattori, XH, NH, DI, HGK, VK, IK, AL, SM, AMaxted, AMoczulska, RM, TN, MP, CP, IP, CS-K, SS, RSchild, MS, RSinha, APS, MStack, MSzczepanska, AT, JT, VU, CZ, JZ. Each author contributed important intellectual content during manuscript drafting or revision and agrees to be personally accountable for the individual's own contributions and to ensure that questions pertaining to the accuracy or integrity of any portion of the work, even one in which the author was not directly involved, are appropriately investigated and resolved, including with documentation in the literature if appropriate. This study has been supported by the European Rare Kidney Disease Network (ERKNet). ERKNet is co-funded by the European Union within the framework of the Third Health Programme “ERN-2016 - Framework Partnership Agreement 2017-2021.” The funders had no role in study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication. The authors declare that they have no relevant financial interests. We are grateful to the European Society of Paediatric Nephrology (ESPN) and the International Paediatric Nephrology Association (IPNA) for their support in administering this study. We are grateful to all colleagues and pediatric nephrology centers contributing cases to this study. Aspects of this work were presented in abstract form at the 53rd ESPN Annual Meeting held in Amsterdam, The Netherlands, in September 2021. Received February 11, 2022. Evaluated by 2 external peer reviewers, with direct editorial input from a Statistics/Methods Editor, an Associate Editor, and the Editor-in-Chief. Accepted in revised form May 18, 2022.

PY - 2023/1

Y1 - 2023/1

U2 - 10.1053/j.ajkd.2022.05.013

DO - 10.1053/j.ajkd.2022.05.013

M3 - Letter

C2 - 35810826

AN - SCOPUS:85136711903

SN - 0272-6386

VL - 81

SP - 119

EP - 122

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

IS - 1

ER -